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ABSTRACT 
Melanoma incidence is increasing. We evaluated risk of melanoma death after diagnosis of non7
melanoma skin cancer (NMSC).  
We followed 77,288 female American nurses from the Nurses’ Health Study from 1986 to 2012. 
We used Cox proportional hazards models to determine the hazard ratio (HR) of lethal and non7
lethal melanoma diagnosis and melanoma death, according to personal NMSC history. Among 
melanoma cases, we examined the HR of melanoma death and the odds ratio (OR) of melanoma 
with a Breslow thickness ≥ 0.8mm or Clark’s level of IV and V according to history of NMSC.  
We documented 930 melanoma cases without NMSC history and 615 melanoma cases with 
NMSC history over 1.8 million person7years.  The multivariate7adjusted HR (95% confidence 
interval) of melanoma death associated with personal history of NMSC was 2.89 (1.8574.50). 
Women with history of NMSC were more likely to develop non7lethal melanoma than lethal 
melanoma (HR (95% CI): 2.31 (2.05–2.60) vs. 1.74 (1.0572.87)). Among melanoma cases, 
women with history of NMSC had a non7significant decreased risk of melanoma deaths (0.87 
(0.5571.37)), Breslow thickness ≥0.8mm (0.85 (0.5971.21)) and Clark’s levels IV and V 
(0.81(0.5271.24)).  
Women with NMSC history were less likely to be diagnosed with a lethal melanoma than a non7
lethal melanoma, but overall rate of melanoma diagnosis was increased in both subtypes, leading 
to the increased risk of subsequent melanoma death. Our findings suggest the continued need for 
dermatologic screening for patients after NMSC diagnosis, given increased melanoma risk. Early 
detection among NMSC patients may decrease deaths from subsequent melanoma. 
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INTRODUCTION 
The incidence of cutaneous melanoma (melanoma) has been increasing steadily in recent 
decades. The American Cancer Society estimates that in 2017 approximately 87,000 new cases 
of melanoma will be diagnosed, and that over 9,000 people will die from the disease.
1
 Although 
early melanoma can be treated cost7effectively, the cost for the care of a melanoma patient can 
skyrocket with advanced disease.
2
 The costs in the 67month terminal period have been estimated 
to account for 90% of the healthcare cost of any given melanoma patient, and the care required 
by a melanoma patient with advanced disease has been estimated to cost as much as that needed 
for a colorectal cancer patient.
2
 With the increasing burden of disease, prevention and early 
detection are critical in curbing the devastating effects of melanoma on the health of the public. 
Several risk factors have been described for melanoma. There are certain non7modifiable 
risk factors in the development of melanoma such as high number of nevi, family history of 
melanoma, light skin complex, and certain genetic mutations.
2
 Modifiable risk factors for 
melanoma include ultraviolet (UV) light exposure and the use of artificial sunlamps.
3,4,5,6
 While 
many markers of UV light exposure have been studied as a means to help risk7stratify patients, 
they are less useful clinically. For example, a study that assessed 257OH7vitamin D levels found 
that higher levels, conceivably a marker of more sun exposure, increased the risk of the 
development of melanoma and non7melanoma skin cancer (NMSC).
7,8 
However, Vitamin D 
levels are not checked routinely, and it would be costly to do so purely for the purposes of risk7
stratifying patients. 
Rather, we would pose that personal history of NMSC is a critical part of the patient’s 
medical history that indicates past high levels of UV exposure. As such, a patient’s NMSC 
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history may portend a higher risk of melanoma and subsequent risk of death from melanoma. 
Indeed, prospective studies showed that NMSC history is associated with a higher risk of certain 
cancers, including melanoma.
9, 10
 However, literature on personal history of NMSC and the risk 
of death from melanoma is lacking. Additionally, there have been no reports of risk associated 
with particular histopathologic features such as depth of invasion of each case of melanoma. We 
sought to use a large prospective cohort to examine the relationship between personal history of 
NMSC and future risk of not only melanoma, but melanoma death.  
METHODS 
Study Population 
The Nurse’s Health Study (NHS) began in 1976 when 121,701 American registered nurses aged 
30755 were enrolled and filled out a questionnaire regarding lifestyle and personal health 
information. Since then, surveys have been sent out to participants biennially to collect data 
prospectively. Response rates have been over 90% in follow7up. Our study period includes data 
collected in surveys from 1986 to 2012. Only Caucasian patients were included in our analysis, 
given the differing risks of melanoma based on ethnicity.
10
 Our study was approved by the 
Human Research Committee of the Brigham and Women’s Hospital (Boston, MA). 
Assessment of NMSC 
Participants were asked about receiving a diagnosis of “basal cell skin cancer,” “squamous cell 
skin cancer,” among other diagnoses every two years since 1986. With participants’ permission, 
their medical records were reviewed to confirm self7reported diagnoses of squamous cell 
carcinoma. Self7reported basal cell carcinomas were not verified by medical records given prior 
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studies demonstrating >90% validity.
12 
Given the way data are collected, these are treated as 
“first NMSC.” 
Assessment of melanoma and death 
Participants have self7reported the diagnosis of “cutaneous melanoma” every two years since 
1986. After self reporting the diagnosis of melanoma, permission was sought to review medical 
records, including any pathological reports. Only confirmed invasive cases were included in the 
current study, and self7reported cases that could not be confirmed were excluded. Information 
collected in addition to time of first melanoma diagnosis included major histopathologic factors, 
such as Breslow depth and Clark’s level. Death events were reviewed in one of three ways. 
Deaths were reported by next of kin or by the US Post Office. Additionally, a search was made 
in the National Death Index for participants who did not respond to surveys. Death certificates 
and when necessary, medical records were used to determine the date of death. More than 98% 
of deaths in the NHS were confirmed by one of these methods.
13
 Furthermore, cause of death 
was determined from death certificates by blinded physician reviewers. This was supplemented 
with family or health7care provider interviews, as well as medical records. The primary cancer 
was recorded as the cause of death in cases of fatal metastatic disease. Of note, patients who 
reported both melanoma and NMSC for the first time in one questionnaire cycle were excluded. 
Assessment of covariates 
Covariate information was collected by self7reported questions in biennial surveys. This included 
information on age, smoking (never, past, or current smokers), alcohol intake (0, 074.9, 579.9, or 
≥10 g/d), body mass index (<25, 25729.9, ≥30 kg/m
2
), and physical activity (in quintiles, 
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metabolic equivalent hours/wk). Certain factors were not asked biennially but rather at certain 
time points. These included the following factors: childhood reaction to sun (tan without burn, 
burn, or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, 
or deep tan), times of sunburns (0, 172, 375, or ≥6), hair color (red, blonde, light brown, or dark 
brown/black), family history of melanoma (yes or no), and cumulative UV flux (in quintiles). 
UV flux was calculated for each participant based on her state of residence using a previously 
described method.
14 
Statistical Analysis
 
All analyses were carried out using SAS (version 9.4; SAS Institute Inc., Cary, NC). All P values 
were 27tailed with the significance level set at P <0.05. The study baseline was 1986, and 
association of NMSC history with subsequent melanoma diagnosis and melanoma death were 
examined until 2012.  
We calculated person7years of follow7up from baseline to death or end of follow7up, whichever 
came first. Melanoma deaths were considered the major end point, whereas deaths from other 
causes were censored. Using a Cox proportional hazards model stratified by age and 27year 
intervals, we calculated hazard ratios (HRs) for melanoma death comparing participants with and 
without a history of NMSC. The analyses were adjusted for the previously mentioned covariates 
(BMI, smoking, alcohol intake, physical activity, childhood reaction to sun, number of sunburns, 
family history for melanoma, hair color, ability to tan, UV flux, and physical exam frequency). 
Missing data for any covariate required creation of an indicator variable. In secondary analysis, 
we looked at the association between prior history of NSMC and incident cases of both lethal 
and non7lethal melanoma. In this analysis, follow7up was ended based on date of melanoma 
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diagnosis, death from any cause, or end of follow7up period, whichever came first. Similarly, we 
used a Cox proportional hazards model with adjustment for the same covariates. 
Among melanoma cases, we further examined whether a history of NMSC portended a worse 
prognosis by analyzing the rate of death from melanoma. Participants were included from time 
of diagnosis of melanoma and followed until either end of follow7up time or death from any 
cause, whichever came first. Our predetermined end point was melanoma death, whereas death 
from any other cause was censored. As above, we used a Cox proportional hazards model with 
time in months since diagnosis as the time variable to calculate HRs, adjusting for the same 
covariates. We also created an additional model adjusting for Breslow thickness and Clark’s 
level. Events (melanoma death) were compared only among participants who were at the same 
month of follow7up to control for confounding since time of diagnosis. Then, using the logistic 
regression, we calculated odds ratios (OR) to examine the association between personal history 
of NMSC and Breslow thickness (defined as <0.8 mm or ≥0.8 mm) and Clark’s Level (defined 
as I, II, and III or IV and V), adjusting for the same aforementioned covariates. A cutoff of 0.8 
mm for Breslow thickness was used in accordance with new staging guidelines published by the 
American Joint Committee on Cancer (AJCC).
15
  
 
RESULTS 
A total of 930 of melanoma patients had no personal history of NMSC, while 615 did carry a 
prior diagnosis of NMSC. Baseline characteristics are shown in Table 1. Compared to those 
without personal history of NMSC, women with personal history of NMSC were older and more 
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likely to have family history of melanoma, have red or blonde hair, have tendency to burn 
instead of tan, and have more sunburns.  In addition, women with personal history of NMSC had 
more frequent physical exams and were less likely to develop Clark’s level IV and V melanoma. 
Median age at diagnosis of first NMSC was 65 years. 
When evaluating HR of melanoma death associated with personal history of NMSC, the age7
adjusted HR and 95% confidence interval (CI) was 2.99 (1.94 7 4.62). When covariates other 
than age were included in the model, the multivariate7adjusted HR was 2.89(1.8574.50) (Table 
2).  
We examined the risk of developing either a lethal or non7lethal melanoma depending on prior 
history of NMSC. The mean and median number of months between first NMSC and first 
melanoma were 112 and 95 respectively. The age7adjusted HR and 95%CI for developing a 
lethal melanoma for those with a history of NMSC was 1.97 (1.21 – 3.22) when compared to 
those without NMSC history. Of note, we controlled for age carefully using a two year interval 
in our Cox model. In multivariate analysis, this HR was 1.74 (1.05 – 2.87). For the risk of non7
lethal melanoma, the HRs for age7adjusted and multivariate7adjusted modeling were 2.65 (2.36 – 
2.98) and 2.31 (2.05 – 2.60) (Table 3). These data indicated a higher risk of being diagnosed with 
a non7lethal melanoma than a lethal melanoma among those with personal history of NSMC 
diagnosis. 
Furthermore, in analysis limited to melanoma patients, comparing those with personal history of 
NMSC to those without any such history, we found a HR of 0.83 (0.54 – 1.29) for melanoma 
death in the age7adjusted model. Multivariate modeling revealed a HR of 0.85 (0.54 – 1.33), and 
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in further multivariate modeling with the addition of controlling for Breslow thickness and 
Clark’s level, the HR was 0.87 (0.55 – 1.37) (Table 4). 
Finally, among melanoma patients, we examined the OR of having a “thicker” melanoma 
(Breslow thickness ≥ 0.8 mm) in relation to personal history of NMSC. The age7adjusted HR 
(95%CI) was 0.85 (0.61 – 1.19), and the multivariate7adjusted model yielded an HR of 0.85 
(0.59 – 1.21) (Table 5). We observed similar results for the Clark’s level. Women with personal 
history of NMSC had an age7adjusted HR of 0.85 (0.5871.26) and multivariate7adjusted HR of 
0.81 (0.5271.24) for developing Clark’s level IV and V melanoma (Table 6).  
 
DISCUSSION 
Our data indicate that personal history of NMSC predicts not only a higher risk of death from 
melanoma, but also was associated with an increased risk of both lethal and non7lethal 
melanomas. Importantly, the magnitude of this positive association was greater for non7lethal 
melanomas than for lethal melanomas. 
Our study demonstrates that one aspect of a patient's medical history, in this case a prior 
diagnosis of NMSC, is an important factor when considering melanoma screening. We show that 
a prior diagnosis of NMSC is associated with an increased risk of subsequent melanoma 
diagnosis. Personal history of NMSC diagnosis indicates higher UV exposure history, the 
increased risk of subsequent melanoma diagnosis is not surprising. In addition, melanoma and 
NMSC share similar non7modifiable host factors, including light skin complex, sunburns and 
family history of skin cancer. These may lead us to believe that personal history of NMSC 
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diagnosis would be associated with more severe melanoma at time of diagnosis. However, we 
observed that personal history of NMSC diagnosis predicted an increased risk of non7lethal 
melanoma greater than that of lethal melanoma.  
While a history of NMSC diagnosis increases the risk of melanoma diagnosis across the board, it 
may also lead to earlier detection, making it less likely that the melanoma diagnosed will be 
lethal. The increased rate of diagnosis of non7lethal melanomas that we observed likely stems 
from the increased surveillance of patients with personal history of NMSC diagnosis due to their 
higher likelihood of regular skin checks with a dermatologist or healthcare professional. This 
shows a benefit of frequent skin checks, leading to a propensity toward diagnosing non7lethal 
melanomas. These findings are of important clinical significance, as we demonstrate that 
although personal history of NMSC diagnosis increases subsequent melanoma risk, the potential 
benefit of early detection can help mitigate the adverse effects of the modifiable risk factors to 
which NMSC patients have already exposed themselves. We find this to be a critical message to 
our patients and the healthcare community. NMSC history portends a higher risk of melanoma 
diagnosis in women, but that risk can be mitigated with appropriate surveillance. 
Our study has several strengths: the prospective study design, high survey response rate, large 
sample size, detailed covariate information allowing for the ability to control for a variety of host 
factors, and long follow7up. Additionally, surveys were collected from participants from a 
variety of locations in the United States, and the pathologic confirmation of both SCCs and 
melanomas by medical record review is methodologically rigorous. However, our study also has 
limitations. Our study was limited to white, well7educated female health professionals, making 
our results less generalizable to the general public. However, the fact that our population 
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comprised healthcare professionals implies better follow7up for their own health issues in that 
reporting may be more accurate and participants may be more likely to follow7up appropriate 
with clinicians. As such, our calculations are more likely to represent true estimates in ideal 
circumstances, which is helpful when quoting risks for patients. Our study focused on women 
and some studies have shown that the largest epidemiologic group among whom melanoma 
diagnosis is currently increasing is young women,
6
 lending our data ongoing vital importance. 
Our findings suggest the continued need for dermatologic screening for patients after NMSC 
diagnosis, with attention paid to the increased risk of melanoma. Early detection among NMSC 
patients may help decrease their deaths from subsequent melanoma. 
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Table 1. Agestandardized baseline characteristics of participants with melanoma by personal 
history of NMSC
1
  
1
 All values shown are for the time of melanoma diagnosis or the questionnaire cycle closest to the 
melanoma diagnosis year except where otherwise noted. All variables other than age at diagnosis were 
age (at diagnosis)7adjusted 
2
 Skin exam may not be included in the physical exam. 
 
Personal history of NMSC 
          no yes  
n 930 615  
Age at diagnosis, years, mean (SD) 62.4 (10.8) 69.0 (9.0)  
Body mass index, kg/m
2
,  mean (SD) 26.1(4.8) 25.9(4.7)  
Current smoking, % 8.2 7.0  
Alcohol intake, g/d,  mean (SD) 6.5(10.0) 7.1(11.1)  
Physical activity, metabolic equivalents hours/week, mean (SD) 15.3(18.4) 16.9(19.3)  
Family history of melanoma, % 9.2 12.1  
Red or blonde hair, % 21.0 26.0  
Childhood/adolescent tendency to sunburn or blistering response, % 44.2 55.4  
Childhood/adolescent tendency to average to deep tanning response, 
% 
62.9 50.3  
Number of sunburns, 6 or more, % 57.9 71.1  
UV flux, ×10
74
 RB units, mean (SD) 124.7(25.5) 126.5(26.9)  
Breslow thickness, mm, mean (SD)   1.0(1.2) 0.9(1.0)  
Clark’s level IV or V, %  28.2 25.5  
Body site (%)    
  Head and neck  17.4 20.0  
  Trunk 27.2 28.7  
  Limbs 55.4 51.3  
Physical exam frequency
2
 (%) 84.7(23.8) 86.5(19.3)  
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Table 2. HRs (95% CIs) for the association between personal history of NMSC and risk of 
melanoma death  
 Personal history of NMSC 
 no yes 
Deaths/Person7years   53/1571590 38/284214 
Age7adjusted HR (95% CI) 1.00 2.99(1.9474.62) 
Multivariate7adjusted HR
1 
(95% CI) 1.00 2.89(1.8574.50) 
1 
Multivariate7adjusted analyses were performed adjusting for age, smoking (never, past, or current 
smokers), physical activity (in quintiles, metabolic equivalent hours/wk), body mass index (<25, 25729.9, 
≥30 kg/m
2
), alcohol intake (0, 074.9, 579.9, or ≥10 g/d), childhood reaction to sun (tan without burn, burn, 
or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, or deep tan), 
times of sunburns (0, 172, 375, or ≥6), hair color (red, blonde, light brown, or dark brown/black), family 
history of melanoma (yes or no), cumulative UV flux (in quintiles) and physical exam frequency. An 
indicator variable was created for a missing value for each covariate.   
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Table 3. HRs (95% CIs) for the association between personal history of NMSC and risk of incident 
lethal melanoma and nonlethal melanoma 
                 Personal history of NMSC 
 no yes 
  Lethal melanoma   
  Cases/Person7years   67/1563369 24/278654 
  Age7adjusted HR (95% CI) 1.00 1.97 (1.2173.22) 
  Multivariate7adjusted HR
1 
(95% CI) 1.00 1.74 (1.0572.87) 
  Nonlethal melanoma   
  Cases/Person7years   888/156339 501/278654 
  Age7adjusted HR (95% CI) 1.00 2.65 (2.3672.98) 
  Multivariate7adjusted HR
1 
(95% CI) 1.00 2.31 (2.0572.60) 
1 
Multivariate7adjusted analyses were performed adjusting for age, smoking (never, past, or current 
smokers), physical activity (in quintiles, metabolic equivalent hours/wk), body mass index (<25, 25729.9, 
≥30 kg/m
2
), alcohol intake (0, 074.9, 579.9, or ≥10 g/d), childhood reaction to sun (tan without burn, burn, 
or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, or deep tan), 
number of sunburns (0, 172, 375, or ≥6), hair color (red, blonde, light brown, or dark brown/black), family 
history of melanoma (yes or no), cumulative UV flux (in quintiles), and physical exam frequency. An 
indicator variable was created for a missing value for each covariate.   
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Table 4. HRs (95% CIs) for the association between personal history of NMSC and risk of 
melanoma deaths among melanoma cases only
1
 
       Personal history of NMSC 
 no yes 
Age7adjusted HR (95% CI) 1.00 0.83 (0.5471.29) 
Multivariate7adjusted HR
2
 (95% CI) 1.00 0.85 (0.5471.33) 
Multivariate7adjusted HR
3
 (95% CI) 1.00 0.87 (0.5571.37) 
1
 Melanoma cases entered the followed7up only after they were diagnosed.  
 
2 
Multivariate7adjusted analyses were performed adjusting for age, smoking (never, past, or current 
smokers), physical activity (in quintiles, metabolic equivalent hours/wk), body mass index (<25, 25729.9, 
≥30 kg/m
2
), alcohol intake (0, 074.9, 579.9, or ≥10 g/d), childhood reaction to sun (tan without burn, burn, 
or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, or deep tan, for 
Nurses’ Health Study only), number of sunburns (0, 172, 375, or ≥6), hair color (red, blonde, light brown, 
or dark brown/black), family history of melanoma (yes or no), cumulative UV flux (in quintiles), and 
physical exam frequency. An indicator variable was created for a missing value for each covariate.  
3 
Additionally adjusting for Breslow thickness and Clark’s level.  
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Table 5. ORs (95% CIs) for the association between personal history of NMSC and the risk of 
Breslow thickness ≥ 0.8 mm of melanoma 
 
           Personal history of NMSC 
 no yes 
Breslow thickness <0.8 mm   289 161 
Breslow thickness ≥0.8 mm   170 95 
Age7adjusted OR (95% CI) 1.00 0.85 (0.6171.19) 
Multivariate7adjusted OR
2
 (95% CI)
2 
1.00 0.85 (0.5971.21) 
1 Analysis only among melanoma cases.   
2 Multivariate7adjusted analyses were performed adjusting for age, smoking (never, past, or current 
smokers), physical activity (in quintiles, metabolic equivalent hours/wk), body mass index (<25, 25729.9, 
≥30 kg/m2), alcohol intake (0, 074.9, 579.9, or ≥10 g/d), childhood reaction to sun (tan without burn, burn, 
or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, or deep tan, for 
Nurses’ Health Study only), number of sunburns (0, 172, 375, or ≥6), hair color (red, blonde, light brown, 
or dark brown/black), family history of melanoma (yes or no), cumulative UV flux (in quintiles), and 
physical exam frequency. An indicator variable was created for a missing value for each covariate.  
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Table 6. ORs (95% CIs) for the association between personal history of NMSC and the risk of 
Clark’s level IV and V melanoma 
 
1 Analysis only among melanoma cases.   
2 Multivariate7adjusted analyses were performed adjusting for age, smoking (never, past, or current 
smokers), physical activity (in quintiles, metabolic equivalent hours/wk), body mass index (<25, 25729.9, 
≥30 kg/m2), alcohol intake (0, 074.9, 579.9, or ≥10 g/d), childhood reaction to sun (tan without burn, burn, 
or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, or deep tan, for 
Nurses’ Health Study only), number of sunburns (0, 172, 375, or ≥6), hair color (red, blonde, light brown, 
or dark brown/black), family history of melanoma (yes or no), cumulative UV flux (in quintiles), and 
physical exam frequency. An indicator variable was created for a missing value for each covariate.  
  
 
 
 
 
 
 
 
 
           Personal history of NMSC 
 no yes 
Clark’s level I, II and III   321 151 
Clark’s level IV and V 112 63 
Age7adjusted OR (95% CI) 1.00 0.85(0.5871.26) 
Multivariate7adjusted OR
2
 (95% CI)
2 
1.00 0.81(0.5271.24) 
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